在单细胞水平上对主要癌症进行尖端的耐药性分析
Tianyu Liu1, Zhiyuan Cao1, Wenxin Long2
1Yale University, New Haven, 06520, CT, USA.
Cancer treatment and research communications
|December 1, 2025
概括
癌细胞可能会对治疗产生抵抗力,这对癌细胞构成重大挑战. 本综述探讨了单细胞分析如何揭示耐药性和耐药性的机制,这对于克服治疗失败至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 癌细胞的耐药性是有效治疗的主要障碍.
- 了解耐药性和耐药性的机制对于改善患者的治疗结果至关重要.
- 瘤异质性使细胞水平对药物耐药性的分析变得复杂.
研究的目的:
- 审查最近在分析细胞水平耐药性的进展.
- 探索药物耐药机制的来源,动力学和相互作用.
- 突出单细胞多原子测序在理解药物耐受性和耐药性的作用.
主要方法:
- 关于单细胞分析技术的当前文献的审查.
- 讨论用于药物耐药性研究的单细胞多原子测序.
- 分析药物耐药性的瘤间和瘤内部异质性.
主要成果:
- 单细胞分析为研究耐药性来源和发展提供了有前途的途径.
- 细胞状态和癌症异质性与耐药性有关.
- 单细胞多原子测序是研究耐药性和耐药性的强大工具.
结论:
- 单细胞分析的进步对于理解和克服癌症抗药性至关重要.
- 需要进行方法改进,以充分利用单细胞多原子数据.
- 针对细胞水平的耐药性机制可以改善癌症治疗策略.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


